{
    "title": "Amgen wins approval for second biotech cholesterol drug",
    "url": "https://www.dailymail.co.uk/wires/ap/article-3213515/Amgen-wins-approval-second-biotech-cholesterol-drug.html",
    "date": "2015-08-27",
    "keywords": [
        "cholesterol",
        "drug",
        "heart",
        "amgen",
        "approval",
        "repatha",
        "disease",
        "year",
        "ldl",
        "benefit",
        "biotech",
        "gmt",
        "august",
        "class",
        "statin",
        "price",
        "praluent",
        "sanofi",
        "health",
        "pharmacy",
        "manager",
        "statement",
        "risk",
        "substance",
        "pcsk9",
        "percent",
        "analyst",
        "press",
        "email",
        "washington",
        "inc",
        "medicine",
        "pricey",
        "tag",
        "use",
        "food",
        "administration",
        "thursday",
        "history",
        "attack",
        "stroke",
        "schedulethousand",
        "partner",
        "regeneron",
        "labeling",
        "wider",
        "group",
        "care",
        "system",
        "wave",
        "baby",
        "market",
        "medication",
        "discountsexpress",
        "competition",
        "express",
        "company",
        "meeting",
        "monththe",
        "advance",
        "introduction",
        "salesbut",
        "prospect",
        "control",
        "prevention",
        "cause",
        "death",
        "lowdensity",
        "lipoprotein",
        "way",
        "ability",
        "blood",
        "waxlike",
        "percentpfizer",
        "problem",
        "lifesaving",
        "coverage",
        "committee",
        "spokeswoman",
        "cost",
        "adherence",
        "conditionsdeutsche",
        "bank",
        "robyn",
        "credit",
        "vamil",
        "divan",
        "pfizer"
    ],
    "category": [
        "wires",
        "ap"
    ]
}